The pharmacological aspects of the treatment of acromegaly

Prediabetes: diagnostic aspects, clinical features, and emerging therapeutic opportunities, with a focus on Vitamin D.

Journal of endocrinological investigation·2026

X-Linked Hypophosphatemia: Role of Fibroblast Growth Factor 23 on Human Skeletal Muscle-Derived Cells.

Calcified tissue international·2025

Pathophysiology and evaluation of bone health in adrenal diseases.

Endocrine·2025

Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society.

Pituitary·2025

Hypophosphatemic rickets in an Italian multicentric cohort of 24 subjects: a clinical and molecular characterisation.

Endocrine·2025

Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs).

Pituitary·2025

Alpha-ketoglutarate ameliorates systemic sclerosis-associated fibrosis by restoring endothelial function.

Pharmacological research·2026

Nifedipine-modulated gut microbiota attenuates hypertensive vascular injury through Bifidobacterium-associated inosine-Adora2b signaling.

Pharmacological research·2026

Dysregulated Metal Homeostasis in Alzheimer's Disease: From Pathological Modulators to Therapeutic Targets.

Pharmacological research·2026

SERINC3 promotes oral squamous cell carcinoma progression and mitochondrial metabolic reprogramming involving c-MET/JNK/PGC-1α axis.

Pharmacological research·2026

Low-dose Juglone Attenuates Pressure Overload-Induced Cardiac Hypertrophy through Lys207-dependent FoxO1 activation and Mitochondrial protection.

Pharmacological research·2026

Exploring the role of histone deacetylases and histone deacetylase inhibitors in obesity and emerging evidence from Anorexia Nervosa.

Pharmacological research·2026

Current perspectives in the pharmacological management of cutaneous and mucosal leishmaniasis.

Expert opinion on pharmacotherapy·2026

New potassium binders: we need them-we do not need them.

Clinical kidney journal·2026

Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity.

Diabetes, obesity, and cardiometabolic CARE·2026

Ketamine in psychiatry: a systematic review of clinical applications, safety considerations, and emerging challenges.

Frontiers in psychiatry·2026

The Impact of Changes to the Payment Restrictions of the National Reimbursement Drug List in China: An Empirical Study Employing a Stacked Difference-in-Differences Approach.

Healthcare (Basel, Switzerland)·2026

Ibogaine for Substance Use Disorders.

Advances in therapy·2026

Related Experiment Videos

The pharmacological aspects of the treatment of acromegaly

Related Concept Videos

Prediabetes: diagnostic aspects, clinical features, and emerging therapeutic opportunities, with a focus on Vitamin D.

X-Linked Hypophosphatemia: Role of Fibroblast Growth Factor 23 on Human Skeletal Muscle-Derived Cells.

Pathophysiology and evaluation of bone health in adrenal diseases.

Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society.

Hypophosphatemic rickets in an Italian multicentric cohort of 24 subjects: a clinical and molecular characterisation.

Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs).

Alpha-ketoglutarate ameliorates systemic sclerosis-associated fibrosis by restoring endothelial function.

Nifedipine-modulated gut microbiota attenuates hypertensive vascular injury through Bifidobacterium-associated inosine-Adora2b signaling.

Dysregulated Metal Homeostasis in Alzheimer's Disease: From Pathological Modulators to Therapeutic Targets.

SERINC3 promotes oral squamous cell carcinoma progression and mitochondrial metabolic reprogramming involving c-MET/JNK/PGC-1α axis.

Low-dose Juglone Attenuates Pressure Overload-Induced Cardiac Hypertrophy through Lys207-dependent FoxO1 activation and Mitochondrial protection.

Exploring the role of histone deacetylases and histone deacetylase inhibitors in obesity and emerging evidence from Anorexia Nervosa.

Current perspectives in the pharmacological management of cutaneous and mucosal leishmaniasis.

New potassium binders: we need them-we do not need them.

Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity.

Ketamine in psychiatry: a systematic review of clinical applications, safety considerations, and emerging challenges.

The Impact of Changes to the Payment Restrictions of the National Reimbursement Drug List in China: An Empirical Study Employing a Stacked Difference-in-Differences Approach.

Ibogaine for Substance Use Disorders.

Related Experiment Videos

The pharmacological aspects of the treatment of acromegaly

Related Concept Videos

Related Articles